Sexually Transmitted Disease Testing and Uptake of Human Papillomavirus Vaccine in a Large Online Survey of US Men Who Have Sex With Men at Risk for HIV Infection, 2012

National guidelines recommend annual human immunodeficiency virus (HIV)/sexually transmitted disease testing for sexually active men who have sex with men (MSM) and vaccination against human papillomavirus for MSM through age 26. A 2012 online survey of 2,794 MSM found that 51%, 36%, and 14% reporte...

Full description

Saved in:
Bibliographic Details
Published in:Sexually transmitted diseases 2017-01, Vol.44 (1), p.63-67
Main Authors: Kahle, Erin M., Meites, Elissa, Sineath, R. Craig, Nasrullah, Muazzam, Bowles, Kristina E., DiNenno, Elizabeth, Sullivan, Patrick S., Sanchez, Travis
Format: Article
Language:English
Subjects:
Adult
At risk
Gays & lesbians
Health risks
HIV
HIV Infections - diagnosis
HIV Infections - etiology
Homosexuality
Human immunodeficiency virus
Human papillomavirus
Humans
Immune disorders
Immunization
Infections
Internet
Lentivirus
Male
Mass Screening - psychology
Mass Screening - statistics & numerical data
Men
National guidelines
Papillomaviridae
Papillomavirus Infections - prevention & control
Papillomavirus Vaccines - therapeutic use
Patient Acceptance of Health Care - statistics & numerical data
Polls & surveys
Retroviridae
Risk Factors
Sex
Sexual and Gender Minorities - statistics & numerical data
Sexual behavior
Sexually transmitted diseases
Sexually Transmitted Diseases - diagnosis
Sexually Transmitted Diseases - psychology
STD
Surveys and Questionnaires
United States
Uptake
Vaccination
Viruses
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:National guidelines recommend annual human immunodeficiency virus (HIV)/sexually transmitted disease testing for sexually active men who have sex with men (MSM) and vaccination against human papillomavirus for MSM through age 26. A 2012 online survey of 2,794 MSM found that 51%, 36%, and 14% reported receiving human immunodeficiency virus testing, sexually transmitted disease testing, and human papillomavirus vaccination, respectively.
ISSN:0148-5717
1537-4521
DOI:10.1097/OLQ.0000000000000545